MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Beyond the “best contact”: correlation of ai-guided dbs contact distribution and subthalamic nucleus beta physiology in parkinson’s disease patients

    S. Obika, M. Del Alamo, D. Ortiz-Zacarías, C. Fernandez, F. Alonso-Frech (Madrid, Spain)

    Objective: We hypothesized that optimal stimulation setting may involve a muti-contact configuration rather than a single contact with the largest therapeutic window (TW). We aimed…
  • 2026 International Congress

    Psychosis in Parkinson’s Disease Patients Treated with Continuous Subcutaneous Foslevodopa/Foscarbidopa: A Real-World Observational Study.

    M. Angerri Nadal, C. Marzal Espi, R. Gomez Llopico, S. Jauma Classen, M. Calopa Garriga, H. Bejr-Kasem Marco (Barcelona, Spain)

    Objective: To assess the incidence and timing of psychosis (hallucinations and delusions) in Parkinson’s disease patients receiving continuous subcutaneous infusion of foslevodopa/foscarbidopa (CSFLI). Background: CSFLI…
  • 2026 International Congress

    DTI-Based Comparative Analysis of Microstructural Alterations in Parkinson Disease and Atypical Parkinsonism

    H. Lin, W. Dai (guangzhou, China)

    Objective: Diffusion tensor imaging (DTI) holds promising potential for investigating pathological changes in white matter (WM). In recent years, numerous studies worldwide have demonstrated that…
  • 2026 International Congress

    Establishing the Ukrainian Parkinson’s Disease Cohort within GP2: Early Results from the UPGRADE-PD Initiative

    S. Bandrivska, H. Houlden, F. Magrinelli, A. Kolodii, V. Bashynska, I. Halushko, Y. Tsyoma, A. Bondarieva, A. Shevchenko, R. Svistilnik, O. Borysenko, O. Kripchak, L. Maksymova, R. Nasalyk, S. Shkrobot, I. Khubetova, A. Cherkez, P. Marushchenko, T. Slobodin (London, United Kingdom)

    Objective: To describe the early establishment and recruitment outcomes of the Ukrainian Parkinson’s disease cohort within the Global Parkinson’s Genetics Program (GP2). Background: Eastern European…
  • 2026 International Congress

    Shared and Sex-Specific Genetic Risk for Parkinson’s Disease Across European Populations

    H. Leonard, M. Makarious, L. Lange, P. Reyes-Pérez, A. Singleton, C. Blauwendraat (Wasington, USA)

    Objective: To investigate sex-specific autosomal genetic factors associated with PD risk. Background: Parkinson’s disease (PD) affects females and males differently, with differences in prevalence, clinical…
  • 2026 International Congress

    Seven-Year Outcome of Focused Ultrasound Thalamotomy in Tremor Dominant Parkinson’s Disease Patients

    M. Nassar, I. Senderova, M. Katson, A. Sinai, I. Schlesinger (Haifa, Israel)

    Objective: To assess 7-year outcomes of unilateral MRI-guided focused ultrasound (MRgFUS) ventral intermediate nucleus thalamotomy in tremor-dominant Parkinson’s disease (TDPD) patients with levodopa-unresponsive tremor, and…
  • 2026 International Congress

    Deep Brain Stimulation (DBS) For Parkinson’s Disease (PD) Patients Carrying The GBA Gene Variant: Greater-Than-Expected Benefits, Similar Cognitive Decline, But Caution Is Advised Regarding Anxiety And Depression.

    OBP. Bernal-Pacheco, DSP. Poveda-Rodriguez, NTL. Lopez-Gonzalez (Bogota, Colombia)

    Objective: To describe the motor and non-motor response in PD Patients Carrying The GBA Gene Variant under treatment with DBS Background: Parkinson's disease (PD) patients carrying…
  • 2026 International Congress

    The Transcriptomic, Neurotransmitter, and Cell Type Signatures Underlying Pure Fatigue in Early-stage Parkinson’s Disease

    Y. Xiao, S. Wang, Y. Hou, R. Ou, C. Li, W. Song, X. Shi, X. Zhu, H. Shang (Chengdu, China)

    Objective: This study elucidates spatiotemporal functional connectivity of pure fatigue in early Parkinson’s disease (PD) and uncovering underlying gene expression profiles. Background: Fatigue is a…
  • 2026 International Congress

    Nutritional Status as a Modifiable Determinant of Clinical Outcomes in Parkinson’s Disease: A 12-Month Longitudinal Study in Patients Treated with DBS and L-Dopa

    N. Ayo Mentxakatorre, M. Acera Gil, C. Juanes-Moreno, T. Fernandez-Valle, B. Tijero, M. Ruiz-Lopez, JC. Gomez-Esteban, R. Del Pino (Barakaldo, Spain)

    Objective: To analyze longitudinal changes in nutritional status in Parkinson’s disease (PD) patients treated with deep brain stimulation (DBS), compared with pharmacological therapy (L-dopa) and to…
  • 2026 International Congress

    Visualization of Small Brainstem Nuclei With the Ultra-High Performance NeuroEXPLORER PET Camera: a Comparison Study Using 18F-AV133

    N. Prakash, R. Gunn, G. Rizzo, G. Searle, Z. Fan, J. Eberling, G. Tamagnan, J. Seibyl, K. Marek (New Haven, USA)

    Objective: To compare the performance of 18F-AV133 between NeuroEXPLORER (NX) and standard resolution Siemens Biography (mCT) positron emission tomography (PET) cameras in people with Parkinson's…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley